PILLPHARM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PILLPHARM
Largest movements
- Cash +€25,067
up €25,067 (+149%), from €16,860 to €41,927
mainly Net result for the year (+€24,886) and Tax, wage and social debts (+€2,724)
- Receivables within one year +€2,450
up €2,450 (+6.2%), from €39,687 to €42,138
of which Other amounts receivable: +€2,036
- Reserves +€24,886
up €24,886 (+280%), from €8,873 to €33,759
of which Distributable reserves: +€24,886
- Tax, wage and social debts +€2,724
up €2,724 (+216%), from €1,263 to €3,987
- Financial charges -€39,282
down €39,282 (-99.4%), from €39,502 to €221
- Gross operating margin +€17,371
up €17,371 (+144%), from €12,040 to €29,411
- Taxes +€3,679
up €3,679 (+1,196%), from €308 to €3,986
- Depreciation -€1,080
down €1,080 (-52.5%), from €2,057 to €977
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €58,466 | €86,093 | +€27,628 | +47.3% |
| Fixed assets | 21/28 | €1,918 | €2,028 | +€110 | +5.7% |
| Tangible fixed assets | 22/27 | €918 | €1,028 | +€110 | +12.0% |
| Furniture and vehicles | 24 | €918 | €1,028 | +€110 | +12.0% |
| Financial fixed assets | 28 | €1,000 | €1,000 | = | 0.0% |
| Current assets | 29/58 | €56,548 | €84,065 | +€27,517 | +48.7% |
| Amounts receivable within one year | 40/41 | €39,687 | €42,138 | +€2,450 | +6.2% |
| Trade receivables | 40 | €9,242 | €9,656 | +€414 | +4.5% |
| Other amounts receivable | 41 | €30,445 | €32,482 | +€2,036 | +6.7% |
| Cash at bank and in hand | 54/58 | €16,860 | €41,927 | +€25,067 | +149% |
| Total equity and liabilities | 10/49 | €58,466 | €86,093 | +€27,628 | +47.3% |
| Equity | 10/15 | €28,397 | €53,282 | +€24,886 | +87.6% |
| Contributions | 10/11 | €6,386 | €6,386 | = | 0.0% |
| Reserves | 13 | €8,873 | €33,759 | +€24,886 | +280% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €8,873 | €33,759 | +€24,886 | +280% |
| Profit (loss) carried forward | 14 | €13,138 | €13,138 | = | 0.0% |
| Provisions and deferred taxes | 16 | €28,114 | €28,114 | = | 0.0% |
| Provisions for liabilities and charges | 160/5 | €28,114 | €28,114 | = | 0.0% |
| Pensions and similar obligations | 160 | €28,114 | €28,114 | = | 0.0% |
| Amounts payable | 17/49 | €1,956 | €4,698 | +€2,742 | +140% |
| Amounts payable within one year | 42/48 | €1,706 | €4,448 | +€2,742 | +161% |
| Trade debts | 44 | €442 | €460 | +€18 | +4.1% |
| Suppliers | 440/4 | €442 | €460 | +€18 | +4.1% |
| Taxes, remuneration and social security | 45 | €1,263 | €3,987 | +€2,724 | +216% |
| Taxes | 450/3 | €1,263 | €3,987 | +€2,724 | +216% |
| Accrued charges and deferred income | 492/3 | €250 | €250 | = | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,057 | €977 | -€1,080 | -52.5% |
| Other operating charges | 640/8 | €1,348 | €1,160 | -€188 | -13.9% |
| Non-recurring operating charges | 66A | - | €80 | +€80 | |
| Gross operating margin | 9900 | €12,040 | €29,411 | +€17,371 | +144% |
| Operating profit (loss) | 9901 | €8,635 | €27,194 | +€18,560 | +215% |
| Financial income | 75/76B | €1,643 | €1,899 | +€255 | +15.5% |
| Recurring financial income | 75 | €1,643 | €1,899 | +€255 | +15.5% |
| Financial charges | 65/66B | €39,502 | €221 | -€39,282 | -99.4% |
| Recurring financial charges | 65 | €39,502 | €221 | -€39,282 | -99.4% |
| Profit (loss) for the period before taxes | 9903 | -€29,225 | €28,872 | +€58,097 | |
| Income taxes | 67/77 | €308 | €3,986 | +€3,679 | +1,196% |
| Profit (loss) for the period | 9904 | -€29,532 | €24,886 | +€54,418 | |
| Profit (loss) for the period to be appropriated | 9905 | -€29,532 | €24,886 | +€54,418 |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.